Volcano Corp (VOLC) 17.10 $VOLC
Technical Data on Health Care Sector Equities -- Research on Volcano, Masimo, Wright Medical, and Sirona Dental Systems
PR Newswire - Fri May 09, 11:00AM CDT
On Thursday, May 08, 2014, the NASDAQ Composite ended at 4,051.50, down 0.40%, the Dow Jones Industrial Average finished the day 0.20% higher at 16,550.97, and the S&P 500 closed at 1,875.63, down 0.14%. During the trading session, five out of ten sectors finished positive. The S&P 500 Health Care Sector Index ended the day at 664.48, down 0.53%, while the index has advanced 0.78% in the last one month. Investor-Edge has initiated coverage on the following equities: Volcano Corporation (NASDAQ: VOLC), Masimo Corporation (NASDAQ: MASI), Wright Medical Group Inc. (NASDAQ: WMGI) and Sirona Dental Systems Inc. (NASDAQ: SIRO). Free technical research on VOLC, MASI, WMGI and SIRO can be downloaded upon signing up at:
Volcano Has Returned 13.4% Since SmarTrend Recommendation (VOLC)
Comtex SmarTrend(R) - Wed May 07, 5:07PM CDT
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 1 month, Volcano has returned 13.45% as of today's recent price of $16.96.
Volcano Slips into Loss, Misses Ests in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 06, 11:10AM CDT
Following the earnings announcement Volcano's share price dropped 0.2% to $17.5 on May 5.
Upgrade Alert for Volcano (VOLC)
Comtex SmarTrend(R) - Tue May 06, 7:02AM CDT
Volcano (NASDAQ:VOLC) was upgraded from Hold to Buy at Feltl today. The stock closed yesterday at $17.50 on volume of 2.3 million shares, above average daily volume of 734,000. Volcano (NASDAQ:VOLC) has potential upside of 30.9% based on a current price of $17.50 and analysts' consensus price target of $22.90. Volcano shares should first meet resistance at the 50-day moving average (MA) of $20.26 and find additional resistance at the 200-day MA of $21.47.
Why Volcano Corporation Shares Temporarily Erupted
Sean Williams, The Motley Fool - Motley Fool - Mon May 05, 12:42PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Volcano , a developer of precision-guided...
Volcano Corporation Presentation At Bank Of America Merrill Lynch 2014 Health Care Conference To Be Webcast
PR Newswire - Mon May 05, 12:00PM CDT
Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Bank of America Merrill Lynch 2014 Health Care Conference 2014 on Tuesday, May 13.
Volcano Reports First Quarter Results
PR Newswire - Fri May 02, 3:05PM CDT
Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the first quarter of 2014.
Product Launches, Conference Call Schedules, Promotions, and Appointments - Analyst Notes on Theravance, Volcano, Steris, Cyberonics and Kythera
PR Newswire - Thu May 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Theravance Inc. (NASDAQ: THRX), Volcano Corporation (NASDAQ: VOLC), Steris Corp. (NYSE: STE), Cyberonics Inc. (NASDAQ: CYBX) and Kythera Biopharmaceuticals, Inc. (NASDAQ: KYTH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1881-100free.
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Shares of VOLC Down 10.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 30, 11:19AM CDT
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 1 month, Volcano has returned 10.49% as of today's recent price of $17.54.
Volcano Announces Limited Market Release of SyncVision(TM) Technology System
PR Newswire Europe - Fri Apr 25, 7:31AM CDT
- New system allows co-registration of angiography with intravascular imaging (IVUS)
Volcano Corporation Schedules First Quarter Conference Call, Webcast
PR Newswire - Thu Apr 17, 7:00AM CDT
Volcano Corporation (Nasdaq:VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the first quarter of fiscal 2014 on Friday, May 2.
Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock Movements - Analyst Notes on Pfizer, Cytokinetics, Portola Pharmaceuticals, Volcano, and Array BioPharma
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Pfizer Inc. (NYSE: PFE), Cytokinetics, Incorporated (NASDAQ: CYTK), Portola Pharmaceuticals, Inc. (NASDAQ: PTLA), Volcano Corporation (NASDAQ: VOLC), and Array BioPharma, Inc. (NASDAQ: ARRY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Clinical Trial Initiation, Executive Appointments, Priced Offering, FDA Clearance, and Upcoming Conferences - Analyst Notes on Cytokinetics, Quintiles, Kindred, Volcano, and Novadaq
PR Newswire - Tue Apr 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Cytokinetics, Inc. (NASDAQ: CYTK), Quintiles Transnational Holdings, Inc. (NYSE: Q), Kindred Healthcare, Inc. (NYSE: KND), Volcano Corporation (NASDAQ: VOLC), and Novadaq Technologies Inc. (NASDAQ: NVDQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Moving Average Crossover: Great News for Volcano (VOLC)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 5:46AM CDT
Moving Average Crossover: Great News for Volcano (VOLC)?
Volcano Corporation (VOLC) Crumbles: Stock Falls by 5.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:46AM CDT
Volcano Corporation (VOLC) saw a big move last session, breaking the recent trend of the company, as the stock is now trading below the volatile price range of $21.20 to $22.88 in the past one-month time frame.
Caliber Imaging & Diagnostics Appoints Joseph R. Williams as Its First Vice President of Global Marketing
GlobeNewswire - Wed Mar 26, 6:00AM CDT
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has appointed Joseph R. Williams as Vice President of Global Marketing, a newly created position, effective immediately.
Insider Trading Alert - CYN, WRE And VOLC Traded By Insiders
at The Street - Fri Mar 21, 9:30AM CDT
Stocks with insider trader activity include CYN, WRE and VOLC
Technical Data on Health Care Sector Equities -- Research on Volcano, Masimo, Wright Medical, and Sirona Dental Systems
PR Newswire - Fri May 09, 11:00AM CDT
On Thursday, May 08, 2014, the NASDAQ Composite ended at 4,051.50, down 0.40%, the Dow Jones Industrial Average finished the day 0.20% higher at 16,550.97, and the S&P 500 closed at 1,875.63, down 0.14%. During the trading session, five out of ten sectors finished positive. The S&P 500 Health Care Sector Index ended the day at 664.48, down 0.53%, while the index has advanced 0.78% in the last one month. Investor-Edge has initiated coverage on the following equities: Volcano Corporation (NASDAQ: VOLC), Masimo Corporation (NASDAQ: MASI), Wright Medical Group Inc. (NASDAQ: WMGI) and Sirona Dental Systems Inc. (NASDAQ: SIRO). Free technical research on VOLC, MASI, WMGI and SIRO can be downloaded upon signing up at:
Volcano Has Returned 13.4% Since SmarTrend Recommendation (VOLC)
Comtex SmarTrend(R) - Wed May 07, 5:07PM CDT
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 1 month, Volcano has returned 13.45% as of today's recent price of $16.96.
Volcano Slips into Loss, Misses Ests in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 06, 11:10AM CDT
Following the earnings announcement Volcano's share price dropped 0.2% to $17.5 on May 5.
Upgrade Alert for Volcano (VOLC)
Comtex SmarTrend(R) - Tue May 06, 7:02AM CDT
Volcano (NASDAQ:VOLC) was upgraded from Hold to Buy at Feltl today. The stock closed yesterday at $17.50 on volume of 2.3 million shares, above average daily volume of 734,000. Volcano (NASDAQ:VOLC) has potential upside of 30.9% based on a current price of $17.50 and analysts' consensus price target of $22.90. Volcano shares should first meet resistance at the 50-day moving average (MA) of $20.26 and find additional resistance at the 200-day MA of $21.47.
Why Volcano Corporation Shares Temporarily Erupted
Sean Williams, The Motley Fool - Motley Fool - Mon May 05, 12:42PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Volcano , a developer of precision-guided...
Volcano Corporation Presentation At Bank Of America Merrill Lynch 2014 Health Care Conference To Be Webcast
PR Newswire - Mon May 05, 12:00PM CDT
Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Bank of America Merrill Lynch 2014 Health Care Conference 2014 on Tuesday, May 13.
Volcano Reports First Quarter Results
PR Newswire - Fri May 02, 3:05PM CDT
Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the first quarter of 2014.
Product Launches, Conference Call Schedules, Promotions, and Appointments - Analyst Notes on Theravance, Volcano, Steris, Cyberonics and Kythera
PR Newswire - Thu May 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Theravance Inc. (NASDAQ: THRX), Volcano Corporation (NASDAQ: VOLC), Steris Corp. (NYSE: STE), Cyberonics Inc. (NASDAQ: CYBX) and Kythera Biopharmaceuticals, Inc. (NASDAQ: KYTH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1881-100free.
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu May 01, 4:03AM CDT
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
Shares of VOLC Down 10.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 30, 11:19AM CDT
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 1 month, Volcano has returned 10.49% as of today's recent price of $17.54.
Volcano Announces Limited Market Release of SyncVision(TM) Technology System
PR Newswire Europe - Fri Apr 25, 7:31AM CDT
- New system allows co-registration of angiography with intravascular imaging (IVUS)
Volcano Corporation Schedules First Quarter Conference Call, Webcast
PR Newswire - Thu Apr 17, 7:00AM CDT
Volcano Corporation (Nasdaq:VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the first quarter of fiscal 2014 on Friday, May 2.
Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock Movements - Analyst Notes on Pfizer, Cytokinetics, Portola Pharmaceuticals, Volcano, and Array BioPharma
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Pfizer Inc. (NYSE: PFE), Cytokinetics, Incorporated (NASDAQ: CYTK), Portola Pharmaceuticals, Inc. (NASDAQ: PTLA), Volcano Corporation (NASDAQ: VOLC), and Array BioPharma, Inc. (NASDAQ: ARRY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Clinical Trial Initiation, Executive Appointments, Priced Offering, FDA Clearance, and Upcoming Conferences - Analyst Notes on Cytokinetics, Quintiles, Kindred, Volcano, and Novadaq
PR Newswire - Tue Apr 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Cytokinetics, Inc. (NASDAQ: CYTK), Quintiles Transnational Holdings, Inc. (NYSE: Q), Kindred Healthcare, Inc. (NYSE: KND), Volcano Corporation (NASDAQ: VOLC), and Novadaq Technologies Inc. (NASDAQ: NVDQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Moving Average Crossover: Great News for Volcano (VOLC)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 5:46AM CDT
Moving Average Crossover: Great News for Volcano (VOLC)?
Volcano Corporation (VOLC) Crumbles: Stock Falls by 5.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:46AM CDT
Volcano Corporation (VOLC) saw a big move last session, breaking the recent trend of the company, as the stock is now trading below the volatile price range of $21.20 to $22.88 in the past one-month time frame.
Caliber Imaging & Diagnostics Appoints Joseph R. Williams as Its First Vice President of Global Marketing
GlobeNewswire - Wed Mar 26, 6:00AM CDT
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has appointed Joseph R. Williams as Vice President of Global Marketing, a newly created position, effective immediately.
Insider Trading Alert - CYN, WRE And VOLC Traded By Insiders
at The Street - Fri Mar 21, 9:30AM CDT
Stocks with insider trader activity include CYN, WRE and VOLC
